Literature DB >> 6624875

Congenital polycystic kidney disease. Genetically transmitted infantile polycystic kidney disease in C57BL/6J mice.

J Mandell, W K Koch, R Nidess, G M Preminger, E McFarland.   

Abstract

Entities:  

Mesh：

Year:  1983        PMID： 6624875      PMCID： PMC1916305     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  7 in total

1.  PATHOGENESIS OF POLYCYSTIC KIDNEYS. TYPE 1 DUE TO HYPERPLASIA OF INTERSTITIAL PORTIONS OF COLLECTING TUBULES.

Authors:  V OSATHANONDH; E L POTTER
Journal:  Arch Pathol       Date:  1964-05

2.  Congenital polycystic disease of the kidney occurring in mice.

Authors:  B M RUPPLE
Journal:  J Natl Cancer Inst       Date:  1955-04       Impact factor: 13.506

3.  The incidence of congenital diseases and defects in a south Swedish population.

Authors:  J A BOOK
Journal:  Acta Genet Stat Med       Date:  1951

4.  Developmental defects of the kidney. A review of renal development and experimental studies of maldevelopment.

Authors:  J F Crocker; D M Brown; R L Vernier
Journal:  Pediatr Clin North Am       Date:  1971-05       Impact factor: 3.278

5.  Murine congenital polycystic kidney disease: a model for studying development of cystic disease.

Authors:  G M Preminger; W E Koch; F A Fried; E McFarland; E D Murphy; J Mandell
Journal:  J Urol       Date:  1982-03       Impact factor: 7.450

6.  Adrenal corticosteroid-induced renal cystic disease in the newborn hamster.

Authors:  R B Filmer; F A Carone; R G Rowland; J R Babcock
Journal:  Am J Pathol       Date:  1973-09       Impact factor: 4.307

7.  Polycystic disease of kidney, liver and pancreas; a possible patholgenesis.

Authors:  J E Mcgeoch; E M Darmady
Journal:  J Pathol       Date:  1976-08       Impact factor: 7.996
  7 in total
  5 in total

1.  ADP-ribosylation factor-like 3 is involved in kidney and photoreceptor development.

Authors:  Jeffrey J Schrick; Peter Vogel; Alejandro Abuin; Billy Hampton; Dennis S Rice
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

2.  Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.

Authors:  B D Cowley; F L Smardo; J J Grantham; J P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Tubular dilatation in the repair process of ischaemic tubular necrosis.

Authors:  A Shimizu; Y Masuda; M Ishizaki; Y Sugisaki; N Yamanaka
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Cystin genetic variants cause autosomal recessive polycystic kidney disease associated with altered Myc expression.

Authors:  Chaozhe Yang; Naoe Harafuji; Amber K O'Connor; Robert A Kesterson; Jacob A Watts; Amar J Majmundar; Daniela A Braun; Monkol Lek; Kristen M Laricchia; Hanan M Fathy; Shrikant Mane; Shirlee Shril; Friedhelm Hildebrandt; Lisa M Guay-Woodford
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.996

5.  Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.

Authors:  Timothy P Reilly; Michael J Graziano; Evan B Janovitz; Thomas E Dorr; Craig Fairchild; Francis Lee; Jian Chen; Tai Wong; Jean M Whaley; Mark Tirmenstein
Journal:  Diabetes Ther       Date:  2014-01-29       Impact factor: 2.945
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.